Download PDF
Semin Respir Crit Care Med 2001; 22(5): 509-516
DOI: 10.1055/s-2001-18423
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis

Annette Boehler
  • Division of Pulmonary Medicine and Lung Transplant Program, University Hospital, Zurich, Switzerland
Further Information

Publication History

Publication Date:
14 November 2001 (online)

    Permissions and Reprints

ABSTRACT

Lung transplantation for respiratory failure due to lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis is a therapeutic option in selected patients. These indications account for less than 6% of all lung transplant procedures, and experience is relatively scarce. Pulmonary function testing at evaluation usually shows an obstructive pattern in lymphangioleiomyomatosis, whereas histiocytosis presents with a mixed pattern, and sarcoidosis with a restrictive pattern. Lung diffusion capacity is similarly reduced, however, only histiocytosis and sarcoidosis are often associated with pulmonary hypertension. In all three diseases extrapulmonary manifestations, although of different kinds, are common and must be investigated before transplantation to avoid posttransplant diagnostic pitfalls. In all these diseases, single and bilateral transplantation show comparable results. Typical complications in lymphangioleiomyomatosis include intraoperative severe intrathoracic bleeding, posttransplant chylothorax, pneumothorax, and bleeding of angiomyolipomas. In histiocytosis, extrapulmonary manifestations in bones and pituitary gland may progress. These diseases typically recur in the allograft, leading to clinical symptoms in histiocytosis whereas recurrence in lymphangioleiomyomatosis and sarcoidosis is most often asymptomatic. Survival is similar to patients transplanted for other diseases.

KEYWORD

Lung transplantation - lymphangioleiomyomatosis - eosinophilic granuloma - histiocytosis X - sarcoidosis

REFERENCES

  • 1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000.  J Heart Lung Transplant . 2000;  19 909-931
    CrossrefPubMedSearch in Google Scholar
  • 2 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates: The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  Transplantation . 1998;  66 951-956
    PubMedSearch in Google Scholar
  • 3 Yeatman M, McNeil K, Smith J A. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.  J Heart Lung Transplant . 1996;  15 144-149
    PubMedSearch in Google Scholar
  • 4 Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.  Thorax . 1999;  54 254-264
    PubMedSearch in Google Scholar
  • 5 Rappaport D C, Weisbrod G L, Herman S J, Chamberlain D W. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases.  Am J Roentgenol . 1989;  152 961-964
    PubMedSearch in Google Scholar
  • 6 Costello L C, Hartman T E, Ryu J H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.  Mayo Clin Proc . 2000;  75 591-594
    CrossrefPubMedSearch in Google Scholar
  • 7 Ryu J H. Tuberous sclerosis complex and LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 407-418
    Search in Google Scholar
  • 8 Smolarek T A, Wessner L L, McCormack F X, Mylet J C, Menon A G, Henske E P. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.  Am J Hum Genet . 1998;  62 810-815
    CrossrefPubMedSearch in Google Scholar
  • 9 Sullivan E J, Beck G J, Stoller J K. The registry for individuals with lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation New York, NY: Marcel Dekker Inc 1999: 99-110
    Search in Google Scholar
  • 10 NHLBI. Workshop summary: report of workshop on lymphangioleiomyomatosis.  Am J Respir Crit Care Med . 1999;  159 679-683
    PubMedSearch in Google Scholar
  • 11 Boehler A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med . 1996;  335 1275-1280
    CrossrefPubMedSearch in Google Scholar
  • 12 Boehler A, Speich R, Russi E W, Weder W. International survey on lung transplantation in lymphangioleiomyomatosis. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 79-98
    Search in Google Scholar
  • 13 Trulock E P. Lung transplantation: special considerations and outcome in LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 65-78
    Search in Google Scholar
  • 14 Silverstein E, Ellis K, Wolff M, Jaretzki A. Pulmonary lymphangioleiomyomatosis.  Am J Roentgenol . 1974;  120 12-50
    PubMedSearch in Google Scholar
  • 15 Urban T, Lazor R, Lacronique J. Pulmonary lymphangioleiomyomatosis.  Medicine . 1999;  78 321-337
    CrossrefPubMedSearch in Google Scholar
  • 16 Crausman R, Lynch D, Mortenson R. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.  Chest . 1996;  109 131-137
    PubMedSearch in Google Scholar
  • 17 Pigula F A, Griffith B P, Zenati M A, Dauber J H, Yousem S A, Keenan R J. Lung transplantation for respiratory failure resulting from systemic disease.  Ann Thorac Surg . 1997;  64 1630-1634
    CrossrefPubMedSearch in Google Scholar
  • 18 Avila N A, Kelly J A, Chu S C, Dwyer A J, Moss J. Lymphangioleiomyomatosis: abdominopelvic CT and US findings.  Radiology . 2000;  216 147-153
    CrossrefPubMedSearch in Google Scholar
  • 19 Maziak D E, Kesten S, Rappaport D C, Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.  Eur Respir J . 1996;  9 402-405
    CrossrefPubMedSearch in Google Scholar
  • 20 Oesterling J E, Fishman E K, Goldman S M, Marshall F F. The management of renal angiomyolipoma.  J Urol . 1986;  135 1121-1124
    PubMedSearch in Google Scholar
  • 21 Blute M L, Malek R S, Segura J W. Angiomyolipoma: clinical metamorphosis and concepts for management.  J Urol . 1988;  139 20-24
    PubMedSearch in Google Scholar
  • 22 Kennelly M J, Grossman H B, Cho K J. Outcome and analysis of 42 cases of renal angiomyolipoma.  J Urol . 1994;  152 1988-1991
    PubMedSearch in Google Scholar
  • 23 Matsui K, Takeda K, Yu Z-X. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study.  Am J Respir Crit Care Med . 2000;  161 1002-1009
    CrossrefPubMedSearch in Google Scholar
  • 24 Logginidou H, Ao X, Russo I, Henske E P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.  Chest . 2000;  117 25-30
    CrossrefPubMedSearch in Google Scholar
  • 25 Nine J S, Yousem S A, Paradis I L, Keenan R, Griffith B P. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant . 1994;  13 714-719
    PubMedSearch in Google Scholar
  • 26 O'Brien J D, Lium J H, Parosa J F, Deyoung B R, Wick M R, Trulock E P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.  Am J Respir Crit Care Med . 1995;  151 2033-2036
    PubMedSearch in Google Scholar
  • 27 Bittmann I, Dose T B, Müller C, Dienemann H, Vogelmeier C, Löhrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol . 1997;  26 1420-1423
    PubMedSearch in Google Scholar
  • 28 Tazi A, Soler P, Hance A J. Adult pulmonary Langerhans' cell histiocytosis.  Thorax . 2000;  55 405-416
    CrossrefPubMedSearch in Google Scholar
  • 29 Vassallo R, Ryu J H, Colby T V, Hartman T, Limper A H. Pulmonary langerhans'-cell histiocytosis.  N Engl J Med . 2000;  342 1969-1978
    CrossrefPubMedSearch in Google Scholar
  • 30 Delobbe A, Durieu J, Duhamel A, Wallaert B, and the groupe d'etude en pathologie interstitielle de la societe de pathologie thoracique du nord. Determinants of survival in pulmonary Langerhans'cell granulomatosis (histiocytosis X).  Eur Respir J . 1996;  9 2002-2006
    CrossrefPubMedSearch in Google Scholar
  • 31 Schönfeld N, Frank W, Wenig S. Clinical and radiological features, lung function and therapeutic results in pulmonary histiocytosis X.  Respiration . 1993;  60 38-44
    PubMedSearch in Google Scholar
  • 32 Fartoukh M, Humbert M, Capron F. Severe pulmonary hypertension in histiocytosis X.  Am J Respir Crit Care Med . 2000;  161 216-223
    CrossrefPubMedSearch in Google Scholar
  • 33 Kaltsas G A, Powles T B, Evanson J. Hypothalamo-pituitary abnormalities in adult patients with Langerhans' cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.  J Clin Endocrinol Metab . 2000;  85 1370-1376
    CrossrefPubMedSearch in Google Scholar
  • 34 Gabbay E, Dark J H, Ashcroft T. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax . 1998;  53 326-327
    CrossrefPubMedSearch in Google Scholar
  • 35 Egan T M, Detterbeck F C, Keagy B A, Turpin S, Mill M R, Wilcox B R. Single lung transplantation for eosinophilic granulomatosis.  Southern Med J . 1992;  85 551-553
    PubMedSearch in Google Scholar
  • 36 Etienne B, Bertocchi M, Gamondes J-P. Relapsing pulmonary Langerhans' cell histiocytosis after lung transplantation.  Am J Respir Crit Care Med . 1998;  157 288-291
    CrossrefPubMedSearch in Google Scholar
  • 37 Habib S B, Congleton J, Carr D. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation.  Thorax . 1998;  53 323-325
    CrossrefPubMedSearch in Google Scholar
  • 38 Egeler M R, Favara B E, van Meurs M, Laman J D, Claassen E. Differential in situ cytokine profiles of Langerhans'-like cells and T cells in Langerhans' cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.  Blood . 1999;  94 4195-4201
    PubMedSearch in Google Scholar
  • 39 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
    CrossrefPubMedSearch in Google Scholar
  • 40 Judson M A. An approach to the treatment of pulmonary sarcoidosis with corticosteroids.  Chest . 1999;  115 1158-1165
    CrossrefPubMedSearch in Google Scholar
  • 41 Takada K, Ina Y, Noda M, Sato T, Yamamoto M, Morishita M. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis.  J Clin Epidemiol . 1993;  46 359-366
    CrossrefPubMedSearch in Google Scholar
  • 42 Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases.  Respiration . 1994;  61 219-225
    CrossrefPubMedSearch in Google Scholar
  • 43 Du Bois M R. Corticosteroids in sarcoidosis: friend or foe?.  Eur Respir J . 1994;  7 1203-1209
    CrossrefPubMedSearch in Google Scholar
  • 44 Lower E E, Baughman R P. The use of low dose methotrexate in refractory sarcoidosis.  Am J Med Sci . 1990;  299 153-157
    CrossrefPubMedSearch in Google Scholar
  • 45 Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.  Arch Pathol Lab Med . 1995;  119 167-172
    PubMedSearch in Google Scholar
  • 46 Baughman R P, Winget D B, Bowen E H, Lower E E. Predicting respiratory failure in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis . 1997;  14 154-158
    PubMedSearch in Google Scholar
  • 47 Arcasoy S M, Edelman J D, Wahl P M, Blumenthal N, Palevsky H I, Kotloff R M. Characteristics and outcome of patients with sarcoidosis listed for lung transplantation.  Am J Respir Crit Care Med . 2000;  161 A720
    PubMedSearch in Google Scholar
  • 48 Judson M A. Lung transplantation for pulmonary sarcoidosis.  Eur Respir J . 1998;  11 738-744
    PubMedSearch in Google Scholar
  • 49 Viskum K, Vestbo J. The prognosis of extrapulmonary sarcoidosis.  Sarcoidosis . 1994;  11 73-75
    PubMedSearch in Google Scholar
  • 50 Walker S, Mikhail G, Banner N. Medium term results of lung transplantation for end stage pulmonary sarcoidosis.  Thorax . 1998;  53 281-284
    CrossrefPubMedSearch in Google Scholar
  • 51 Martinez F J, Orens J B, Deeb M, Brunsting L A, Flint A, Lynch III P J. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation.  Chest . 1994;  106 1597-1599
    CrossrefPubMedSearch in Google Scholar
  • 52 Martel S, Carre P C, Carrera G, Pipy B, Leophonte P J, and the Toulouse Lung Transplantation Group. Tumour necrosis factor-alpha gene expression by alveolar macrophages in human lung allograft recipient with recurrence of sarcoidosis.  Eur Respir J . 1996;  9 1087-1089
    CrossrefPubMedSearch in Google Scholar
  • 53 Johnson B A, Duncan S R, Ohori N P. Recurrence of sarcoidosis in pulmonary allograft recipients.  Am Rev Respir Dis . 1993;  148 1373-1377
    CrossrefPubMedSearch in Google Scholar
  • 54 Kazerooni E A, Cascade P N. Sarcoidosis: recurrence of primary disease in transplanted lungs.  Radiology . 1994;  192 461-464
    CrossrefPubMedSearch in Google Scholar
  • 55 Muller C, Briegel J, Haller M, and the Munich Lung Transplant Group. Sarcoidosis recurrence following lung transplantation.  Transplantation . 1996;  61 1117-1119
    PubMedSearch in Google Scholar
  • 56 Björtuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.  J Heart Lung Transplant . 1994;  13 24-29
    PubMedSearch in Google Scholar
  • 57 Klemen H, Husain A N, Cagle P T, Garrity E R, Popper H H. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: a PCR-based study on four cases.  Virchows Arch . 2000;  436 365-369
    CrossrefPubMedSearch in Google Scholar
  • 58 Nunley D R, Hattler B, Keenan R J. Lung transplantation for end-stage pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 93-100
    PubMedSearch in Google Scholar